Skip to main content
Medical information Clinical review pending

Genetic Testing

Chr 15q11 Gene Prader-Willi Syndrome Genetic Test

This genetic test identifies alterations in the 15q11 region of chromosome 15 associated with Prader-Willi syndrome (PWS). Using Next-Generation Sequencing (NGS), it aids in the diagnosis and management of this complex genetic disorder.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
Results
Results are typically available within 3 to 4 weeks. Confirm exact turnaround time with the laboratory before booking.
Preparation
No special preparation is typically required for this blood test. Confirm with the laboratory before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Chr 15q11 Gene Prader-Willi Syndrome Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals presenting with symptoms suggestive of Prader-Willi syndrome (e.g., hypotonia, developmental delay, hyperphagia).
  • ✓Individuals with a family history of Prader-Willi syndrome.
  • ✓Genetic counseling for families with concerns about PWS.
  • ✓Confirmation of suspected PWS diagnosis.
  • ✓Prenatal diagnosis in high-risk pregnancies (requires specific counseling).
02

In plain language

What this test helps you understand

This test helps diagnose Prader-Willi syndrome by identifying specific genetic alterations in the 15q11 region of chromosome 15. Early diagnosis allows for appropriate management and intervention.
This genetic test is designed to detect alterations in the 15q11 region of chromosome 15, which are linked to Prader-Willi syndrome (PWS). PWS is a genetic disorder affecting development and health. The test uses Next-Generation Sequencing (NGS) technology for a comprehensive analysis, crucial for accurate diagnosis and management.

This test specifically looks for deletions or mutations in the genes within the 15q11 region. These genetic changes cause the symptoms of PWS, which can include developmental delays, excessive appetite leading to obesity, and behavioral challenges.

Individuals who might benefit from this test include those showing symptoms of PWS (like low muscle tone, developmental delays, or obesity), people with a family history of PWS or related neurological disorders, and parents seeking genetic counseling for children with developmental concerns.

Taking this test can lead to early diagnosis, allowing for timely intervention and management strategies. It also provides valuable information for family planning and genetic counseling. Understanding the genetic basis of PWS can help guide treatment options.

Results are typically available within 3 to 4 weeks. A genetic counselor will help interpret the results and discuss their implications. A positive result indicates genetic changes associated with PWS. A negative result may reduce concerns but doesn't completely rule out the syndrome. Confirm with the laboratory before booking.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is typically required for this blood test. Confirm with the laboratory before booking.
SampleBlood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
MethodologyNext-Generation Sequencing (NGS) targeting the 15q11 region of chromosome 15.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects specific alterations in the 15q11 region. It may not detect all possible genetic changes associated with PWS or other conditions with similar symptoms. A negative result does not completely rule out PWS. Interpretation requires clinical correlation.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Prader-Willi syndrome (PWS) is a complex genetic disorder caused by the loss of function of specific genes on chromosome 15. It affects appetite, growth, metabolism, cognitive function, and behavior.
This test detects specific genetic changes, such as deletions or mutations, in the 15q11 region of chromosome 15, which are known causes of Prader-Willi syndrome.
The test uses advanced Next-Generation Sequencing (NGS) technology, which is highly accurate for detecting the specific genetic changes it targets. However, no test is 100% accurate.
A genetic counselor will help you understand your results. They will explain the findings, discuss their implications for your health or your child's health, and provide guidance on next steps, including management options and family planning.
Insurance coverage varies. Please check with your insurance provider regarding coverage for genetic testing.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp